ECYT
Endocyte, Inc. Common Stock
ECYT
ECYT
Delisted
ECYT was delisted on the 20th of December, 2018.
82 hedge funds and large institutions have $35.8M invested in Endocyte, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Holders
82
Holding in Top 10
–
Calls
$289K
Puts
$35K
Top Buyers
| 1 | +$5.14M | |
| 2 | +$369K | |
| 3 | +$366K | |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$345K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$153K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$459K | |
| 3 | -$368K | |
| 4 |
ERSOT
Employees Retirement System of Texas
Austin,
Texas
|
-$347K |
| 5 |
Morgan Stanley
New York
|
-$322K |